GKIM
GBT

GW&K Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

GW&K Investment Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$4K – 423
2021
Q2 		$4K Hold
100
– – ﹤0.01% 396
2021
Q1 		$4K Sell
100
-42
-30% -$1.93K ﹤0.01% 375
2020
Q4 		$6K Sell
142
-92,174
-100% -$4.54M ﹤0.01% 368
2020
Q3 		$5.09M Sell
92,316
-1,306
-1% -$83K 0.07% 240
2020
Q2 		$5.91M Sell
93,622
-14,845
-14% -$1.02M 0.08% 227
2020
Q1 		$5.54M Sell
108,467
-999
-0.9% -$66.9K 0.1% 211
2019
Q4 		$8.7M Sell
109,466
-35,048
-24% -$2.08M 0.12% 214
2019
Q3 		$7.01M Buy
144,514
+41,642
+40% +$2.17M 0.1% 216
2019
Q2 		$5.41M Sell
102,872
-28,860
-22% -$1.66M 0.08% 228
2019
Q1 		$6.97M Sell
131,732
-21,074
-14% -$1.04M 0.11% 213
2018
Q4 		$6.27M Buy
152,806
+14,319
+10% +$537K 0.12% 196
2018
Q3 		$5.26M Sell
138,487
-825
-0.6% -$36.5K 0.08% 206
2018
Q2 		$6.3M Buy
139,312
+20,503
+17% +$934K 0.1% 204
2018
Q1 		$5.74M Sell
118,809
-26,908
-18% -$1.5M 0.1% 205
2017
Q4 		$5.73M Buy
145,717
+42,519
+41% +$1.59M 0.1% 195
2017
Q3 		$3.2M Buy
+103,198
New +$2.9M 0.05% 203

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

GW&K Investment Management's GBT Position: Q3 2021 in Review

GW&K Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 100 shares — an estimated $4K sold.

GW&K Investment Management first reported a position in GBT in Q3 2017 and held it in 16 quarters. The position peaked at $8.7M in Q4 2019. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

  • GW&K Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • GW&K Investment Management sold 100 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $4K.
  • GW&K Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2017 and held it in 16 quarters.
  • GW&K Investment Management's Global Blood Therapeutics, Inc. position peaked at $8.7M in Q4 2019.
  • 187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on GW&K Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.